文献速递泌尿生殖与妇科肿瘤放疗

多中心HYPRO试验中图像引导放疗局部方案差异:直肠球囊与MRI勾画对肛门直肠剂量及胃肠道毒性的影响

Local Protocol Variations for Image Guided Radiation Therapy in the Multicenter Dutch Hypofractionation (HYPRO) Trial: Impact of Rectal Balloon and MRI Delineation on Anorectal Dose and Gastrointestinal Toxicity Levels.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-08-03

本研究基于HYPRO试验中4个中心572例接受图像引导IMRT的前列腺癌患者,比较不同局部治疗协议下的肛门直肠剂量参数与患者报告胃肠道症状。结果显示,使用MRI勾画(B中心)和直肠球囊(C中心)的中心剂量分布更优,直肠失禁、使用失禁垫及直肠不适发生率显著更低;C中心还观察到排便频率增加(≥4次/天)和黏液丢失发生率更低。PTV margins差异2-3 mm未转化为观察到的毒性差异。

要点

  • MRI勾画和直肠球囊应用与更优的直肠剂量参数和毒性谱相关。
  • PTV margins差异2-3 mm未导致观察到毒性差异。
  • IG-IMRT治疗优化选择对患者日常症状有临床相关性影响。

核心结论

  • 尽管IG-IMRT技术和预设剂量约束可比,剂量分布和毒性率仍存在显著差异。
  • MRI勾画和直肠球囊应用与有利的直肠剂量参数和毒性谱相关。
  • PTV margins差异2-3 mm未转化为观察到的差异。
  • IG-IMRT治疗优化选择对患者日常症状重要且具有临床相关性。

研究设计与样本

  • 从HYPRO试验中选取4个治疗中心共572例接受图像引导IMRT的患者。
  • A中心(n=242)PTV margins 5-6 mm为参考中心;B中心(n=170)margins 7 mm并整合MRI计划;C中心(n=85)margins 7 mm并应用直肠球囊;D中心(n=75)margins 8 mm。
  • 研究方案提供相同肛门直肠剂量约束,局部协议用于进一步治疗优化。
  • 采用t检验比较肛门直肠剂量-表面积直方图。
  • 采用广义线性模型比较随访期间(6个月至4年)直肠症状,调整年龄、随访、治疗臂和激素治疗。

主要发现

  • B中心(MRI勾画)和C中心(直肠球囊)相比A和D中心显示更有利的肛门直肠剂量分布。
  • B和C中心患者报告的直肠失禁、使用失禁垫和直肠不适发生率显著更低。
  • C中心观察到排便频率增加(≥4次/天)和黏液丢失发生率更低。

临床怎么用

  • 对于接受IG-IMRT的前列腺癌患者,可考虑采用MRI勾画或直肠球囊以优化直肠剂量和降低胃肠道毒性。
  • PTV margins在5-8 mm范围内的小幅差异(2-3 mm)可能不影响患者报告毒性,但需结合中心具体方案综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The phase 3 HYpofractionated irradiation for PROstate cancer (HYPRO) trial randomized patients with intermediate- to high-risk localized prostate cancer to conventionally fractionated (78 Gy in 39 fractions) or hypofractionated (64.6 Gy in 19 fractions) radiation therapy. Differences in techniques and treatment protocols were present between participating centers. This study aimed to compare dose parameters and patient-reported gastrointestinal symptoms between these centers. METHODS AND MATERIALS: From the trial population, we selected patients (N=572) from 4 treatment centers who received image guided (IG) intensity modulated radiation therapy (IMRT). Center A (n=242) applied planning target volume (PTV) margins of 5 to 6 mm and was considered the reference center. In center B (n=170, 7-mm margins), magnetic resonance imaging (MRI) was integrated in treatment planning. An endorectal balloon (ERB) was applied in center C (n=85, 7-mm margins). Center D (n=75) applied the largest PTV margins of 8 mm. The study protocol provided identical anorectal dose constraints, and local protocols were applied for further treatment optimization. Anorectal dose-surface histograms were compared by applying t tests. Rectal complaints during follow-up (6 months to 4 years) were compared in a generalized linear model, adjusting for age, follow-up, treatment arm, and hormone therapy. RESULTS: Favorable anorectal dose distributions were found for center B (MRI delineation) and center C (ERB application) as compared with centers A and D. These were associated with significantly lower incidences of patient-reported complaints of rectal incontinence, use of incontinence pads, and rectal discomfort in these centers. Furthermore, lower incidences of increased stool frequency (≥4 per day) and mucous loss were observed for center C. CONCLUSIONS: Despite comparable IG-IMRT techniques and predefined dose constraints, pronounced differences in dose distributions and toxicity rates were observed. MRI delineation and ERB application were associated with favorable rectal dose parameters and toxicity profiles, whereas a 2- to 3-mm difference in PTV margins did not translate into observed differences. We conclude that choices for treatment optimization of IG-IMRT are important and clinically relevant for patients since these affect symptoms experienced in daily life.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Wortel RC, Heemsbergen WD, Smeenk RJ, et al. Local Protocol Variations for Image Guided Radiation Therapy in the Multicenter Dutch Hypofractionation (HYPRO) Trial: Impact of Rectal Balloon and MRI Delineation on Anorectal Dose and Gastrointestinal Toxicity Levels. Int J Radiat Oncol Biol Phys. 2017. PMID: 28943074. doi:10.1016/j.ijrobp.2017.07.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。